Výsledky vyhledávání - Laurent Greillier
- Zobrazuji výsledky 1 - 20 z 37
- Přejít na další stránku
-
1
-
2
-
3
-
4
-
5
-
6
Accuracy of pleural biopsy using thoracoscopy for the diagnosis of histologic subtype in patients with malignant pleural mesothelioma Autor Laurent Greillier, A. Cavaillès, A. Fraticelli, Arnaud Scherpereel, Fabrice Barlési, Gianfranco Tassi, P. Thomas, Philippe Astoul
Vydáno 2007Artigo -
7
Prognostic value of combination of Cyfra 21-1, CEA and NSE in patients with advanced non-small cell lung cancer Autor Fabrice Barlési, Céline Gimenez, Jean-Philippe Torre, C. Doddoli, Julien Mancini, Laurent Greillier, François Roux, J P Kleisbauer
Vydáno 2003Artigo -
8
EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts’ opinion for the treatment of non-small-cell lung cancer in an elderl... Autor Athanasios Pallis, Cesare Gridelli, Jan P. van Meerbeeck, Laurent Greillier, Ulrich Wedding, Didier Lacombe, John J. Welch, Chandra P. Belani, Matti Aapro
Vydáno 2009Revisão -
9
EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer Autor Pascale Tomasini, Cindy Serdjebi, Nataliya Khobta, Philippe Métellus, L’Houcine Ouafik, Isabelle Nanni, Laurent Greillier, Anderson Loundou, Frédéric Fina, Céline Mascaux, Fabrice Barlési
Vydáno 2016Artigo -
10
Association Between Immune-related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Non–small-cell Lung Cancer Autor M. Grangeon, Pascale Tomasini, S. Chaléat, A. Jeanson, M. Souquet-Bressand, Nataliya Khobta, Julien Bermudez, Youssef Trigui, Laurent Greillier, M. Blanchon, Mohamed Boucékine, Céline Mascaux, Fabrice Barlési
Vydáno 2018Artigo -
11
Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expre... Autor Clémence Demerle, Laurent Gorvel, Marielle Mello, Sonia Pastor, Clara Degos, Ana Zarubica, Fabien Angelis, Frédéric Di Fiore, Jacques A. Nunès, Bernard Malissen, Laurent Greillier, Geoffrey Guittard, Hervé Luche, Fabrice Barlési, Daniel Olive
Vydáno 2023Artigo -
12
Diversity of brain metastases screening and management in non-small cell lung cancer in Europe: Results of the European Organisation for Research and Treatment of Cancer Lung Cance... Autor Antonin Lévy, Corinne Faivre‐Finn, Baktiar Hasan, Eléonora De Maio, Anna S. Berghoff, Nicolas Girard, Laurent Greillier, Sylvie Lantuéjoul, Mary O’Brien, Martin Reck, Anne‐Marie C. Dingemans, Silvia Novello, Thierry Berghmans, Benjamin Besse, Lizza Hendriks
Vydáno 2018Artigo -
13
Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC) Autor A. Jeanson, Pascale Tomasini, M. Souquet-Bressand, Nicolas Brandone, Mohamed Boucékine, M. Grangeon, S. Chaléat, Natalyia Khobta, Julie Milia, Laurent Mhanna, Laurent Greillier, Julie Biemar, Isabelle Nanni, L’Houcine Ouafik, Stéphane Garcia, Julien Mazières, Fabrice Barlési, Céline Mascaux
Vydáno 2019Artigo -
14
Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY... Autor Daniel Morgensztern, Benjamin Besse, Laurent Greillier, Rafael Santana‐Davila, Neal Ready, Christine L. Hann, Bonnie S. Glisson, Anna F. Farago, Afshin Dowlati, Charles M. Rudin, Sylvestre Le Moulec, Satwant Lally, Sreeni Yalamanchili, Jürgen Wolf, Ramaswamy Govindan, David P. Carbone
Vydáno 2019Artigo -
15
A Phase 1–2 Study of Rovalpituzumab Tesirine in Combination With Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Extensive-Stage SCLC Autor Jyoti Malhotra, Petros Nikolinakos, Ticiana Leal, Jonathan M. Lehman, Daniel Morgensztern, Jyoti D. Patel, John M. Wrangle, Giuseppe Curigliano, Laurent Greillier, Melissa L. Johnson, Neal Ready, G. Robinet, Satwant Lally, David Maag, Ricardo Santoyo Valenzuela, Vincent Blot, Benjamin Besse
Vydáno 2021Artigo -
16
EORTC Lung Cancer Group survey on the definition of NSCLC synchronous oligometastatic disease Autor Antonin Lévy, Lizza Hendriks, Thierry Berghmans, Corinne Faivre‐Finn, Matteo Giaj Levra, Niccolò Giaj-Levra, Baktiar Hasan, Alessia Pochesci, Nicolas Girard, Laurent Greillier, Sylvie Lantuéjoul, John Edwards, Mary O’Brien, Martin Reck, Benjamin Besse, Silvia Novello, Anne‐Marie C. Dingemans
Vydáno 2019Artigo -
17
EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers Autor Marco Tagliamento, Marie Morfouace, Charalambos Loizides, Júlio Oliveira, Laurent Greillier, Judith Raimbourg, Anne‐Claire Toffart, Thierry Chatellier, Nicolas Cloarec, Ivana Sullivan, Birute Brasiūnienė, M. Duruisseaux, Kersti Oselin, Marie-Sophie Robert, C. Fernandes, Arnaud Poncin, Jean‐Yves Blay, Benjamin Besse, Nicolas Girard
Vydáno 2024Artigo -
18
Real-World efficacy and safety of combination nivolumab plus ipilimumab for Untreated, Unresectable, pleural Mesothelioma: The Meso-Immune (GFPC 04–2021) trial Autor Olivier Bylicki, Florian Guisier, Arnaud Scherpereel, Catherine Daniel, Aurélie Swalduz, Emmanuel Grolleau, Massimo Bernardi, S. Hominal, Jean.Briac Prevost, G. Pamart, Marie.Héléne Marques, Nicolas Cloarec, S. Deshayes, Judith Raimbourg, Rémi Veillon, Youssef Oulkhouir, Clarisse Audigier-Valette, Fabien Subtil, C. Chouaïd, Laurent Greillier
Vydáno 2024Artigo -
19
Shorter Survival in Malignant Pleural Mesothelioma Patients With High PD-L1 Expression Associated With Sarcomatoid or Biphasic Histology Subtype: A Series of 214 Cases From the Bio... Autor Solenn Brosseau, Claire Danel, Arnaud Scherpereel, Julien Mazières, Sylvie Lantuéjoul, J. Margery, Laurent Greillier, Clarisse Audigier-Valette, V. Gounant, Martine Antoine, Denis Moro‐Sibilot, Isabelle Rouquette, Olivier Molinier, R. Corre, Isabelle Monnet, Alexandra Langlais, Franck Morin, Emmanuel Bergot, Gérard Zalcman, Guénaëlle Levallet
Vydáno 2019Artigo -
20
First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743 Autor Solange Peters, Arnaud Scherpereel, Robin Cornelissen, Youssef Oulkhouir, Laurent Greillier, Kaplan Ma, Thomas Talbot, I. Monnet, Sandrine Hiret, Paul Baas, Anna K. Nowak, Nobukazu Fujimoto, Anne S. Tsao, Aaron S. Mansfield, Sanjay Popat, X. Zhang, Nan Hu, David Balli, Thomas E. Spires, Gérard Zalcman
Vydáno 2022Artigo
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Oncology
Cancer
Lung cancer
Chemotherapy
Immunotherapy
Pathology
Biology
Nivolumab
Clinical trial
Ipilimumab
Surgery
Cancer research
Cisplatin
Mesothelioma
Gene
Pemetrexed
Adverse effect
Biochemistry
Confidence interval
Gastroenterology
Hazard ratio
Radiation therapy
Atezolizumab
Clinical endpoint
Colorectal cancer
Disease
Immunohistochemistry
Immunology